By Bryan Koenig ( August 29, 2023, 6:42 PM EDT) -- Different plaintiffs' counsel are fighting among themselves in antitrust litigation alleging Gilead and Teva cut a deal to delay generic versions of HIV drugs, with consumers seeking a piece of a settlement pie even after they lost at trial, and the settling retailers saying Monday the consumers have no claim....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.